In our meta-analysis, to our best knowledge, we analysed all published data for PTPRJ Arg326Gln and Gln276Pro polymorphisms in different cancers (breast, colorectal, oesophagus, head and neck, lung and thyroid cancer). This evidence concerns the gene PTPRJ and thyroid cancer.